Skip to main content
. 2020 Mar 12;9(2):74–84.

Figure 5.

Figure 5

Extent of corneal neovascularization (NV) in group 1 (adipose-derived mesenchymal stem/stromal cell [ADMSC]-treated) vs. group 2 (control) 14 days after corneal injury. Interquartile range demonstrating the corneal NV distal point (height) and area in the ADMSC-treated group vs. the control group. Differences were considered significant at p < 0.001, t-test)